Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BenQ Medical TechnologyROCO:4116 -1.04%81 FCF Margin % is 5.34% as of Dec. 2025, which is 16% below its 10-year median of 6.36. GuruFocus rates ROCO:4116 with a GF Score™ of 81/100 and a GF Value™ of NT$62.38 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 817 Medical Devices & Instruments companies, BenQ Medical Technology ranks better than 62.55% on this metric.
The historical rank and industry rank for BenQ Medical Technology's FCF Margin % or its related term are showing as below:
ROCO:4116'
s FCF Margin % Range Over the Past 10 Years
Min: -10.29 Med: 6.36 Max: 10.73
Current: 4.94
During the past 13 years, the highest FCF Margin % of BenQ Medical Technology was 10.73%. The lowest was -10.29%. And the median was 6.36%.
ROCO:4116's FCF Margin % is ranked better than 62.55% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: -0.54
vs ROCO:4116: 4.94
BenQ Medical Technology FCF Margin % Related Terms
BenQ Medical Technology FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4116 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BenQ Medical Technology FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's FCF Margin % distribution charts can be found below:
* The bar in red indicates where BenQ Medical Technology's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BenQ Medical Technology (ROCO:4116) has a FCF Margin % of 5.34% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BenQ Medical Technology and its competitors. This is 16% below median its historical median of 6.36. According to the industry distribution chart, BenQ Medical Technology ranks #306 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 37.5%.
Is BenQ Medical Technology's FCF Margin % too high?
BenQ Medical Technology's current FCF Margin % of 5.34% is 16% below median its 10-year median of 6.36. Based on the distribution chart, BenQ Medical Technology ranks #306 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, BenQ Medical Technology has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BenQ Medical Technology ranks #306 out of 817 companies for FCF Margin %. This puts BenQ Medical Technology in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BenQ Medical Technology and its competitors. BenQ Medical Technology's current FCF Margin % is 5.34%, which is 16% below median its own 10-year median of 6.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$62.38, compared to a current price of NT$38.20 — trading 38.8% below its estimated fair value. The current FCF Margin % is 5.34%, which is 16% below median its 10-year median of 6.36. BenQ Medical Technology's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current FCF Margin % is 5.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?
Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued.
The current stock price of NT$38.20 is trading 38.8% below its estimated GF Value™ of NT$62.38.
GuruFocus considers BenQ Medical Technology to be Significantly Undervalued.
Key valuation signals for ROCO:4116:
FCF Margin %: 5.34% (16% below median its 10-year median of 6.36)
GF Value™: NT$62.38 vs. price of NT$38.20 (38.8% below fair value)
No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
81GF Score
Get the complete analysis for ROCO:4116
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4116 has been successfully added to your 
